Jules A. Hoffmann

From WikiMD's WELLNESSPEDIA

Jules A. Hoffmann (born August 2, 1941) is a Franco-Luxembourgish biologist. During his career, Hoffmann and his research team unraveled the broad spectrum of mechanism of innate immunity in insects, and he is widely recognized for his contributions to the understanding of the role of the innate immune system in humans.

Early Life and Education[edit]

Hoffmann was born in Echternach, Luxembourg. He studied biology at the University of Strasbourg in France, where he received his PhD in 1969.

Career[edit]

In 1978, Hoffmann became a Research Director of CNRS and, in 1993, he was named a Professor of Immunology at the University of Strasbourg. He served as the President of the French National Academy of Sciences from 2007 to 2008.

Research[edit]

Hoffmann's research primarily focuses on the innate immune response in the fruit fly, Drosophila melanogaster. His work has been instrumental in demonstrating the conserved nature of the innate immune response between insects and mammals. His most notable work, for which he was awarded the Nobel Prize in Physiology or Medicine in 2011, involved the discovery of the role of the Toll-like receptor in innate immunity.

Awards and Honors[edit]

In addition to the Nobel Prize, Hoffmann has received numerous other awards and honors for his work, including the Balzan Prize for Immunological Approaches in Cancer Therapy (2007), and the Keio Medical Science Prize (2010).

Personal Life[edit]

Hoffmann is married to fellow scientist Chantal Ferrand, and they have two children.

See Also[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.